The Prognostic Value of Plasma Ceramides as Cardiovascular Death Markers for Coronary Artery Disease

被引：0
|
作者：
Li, Lin [1 ]
机构：
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Biomarkers; Cardiovascular disease prevention; Metabolomics; Clinical trials; Vascular disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14555
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
    Gorog, Diana A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (24) : 2701 - 2709
  • [2] Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
    Laaksonen, Reijo
    Ekroos, Kim
    Sysi-Aho, Marko
    Hilvo, Mika
    Vihervaara, Terhi
    Kauhanen, Dimple
    Suoniemi, Matti
    Hurme, Reini
    Maerz, Winfried
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Vlachopoulou, Efthymia
    Lokki, Marja-Liisa
    Nieminen, Markku S.
    Klingenberg, Roland
    Matter, Christian M.
    Hornemann, Thorsten
    Juni, Peter
    Rodondi, Nicolas
    Raber, Lorenz
    Windecker, Stephan
    Gencer, Baris
    Pedersen, Eva Ringdal
    Tell, Grethe S.
    Nygard, Ottar
    Mach, Francois
    Sinisalo, Juha
    Luscher, Thomas F.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (25) : 1967 - 1976
  • [3] Prognostic value of proinflammatory markers in patients with documented coronary artery disease
    Berezin, A.
    Kremzer, A.
    Samura, T.
    Berezina, T.
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2013, 12 : S22 - S22
  • [4] Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease:: the AtheroGene study
    Morange, P. E.
    Blankenberg, S.
    Alessi, M. C.
    Bickel, C.
    Rupprecht, H. J.
    Schnabel, R.
    Lubos, E.
    Muenzel, T.
    Peetz, D.
    Nicaud, V.
    Juhan-Vague, I.
    Tiret, L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) : 475 - 482
  • [5] PLASMA CERAMIDES IDENTIFY RESIDUAL CARDIOVASCULAR RISK IN STATIN TREATED CORONARY ARTERY DISEASE PATIENTS
    Laaksonen, R.
    Ekroos, K.
    Sysi-Aho, M.
    Vihervaara, T.
    Kauhanen, D.
    Hilvo, M.
    Hurme, R.
    Pedersen, E. Ringdal
    Tell, G.
    Nygard, O.
    [J]. ATHEROSCLEROSIS, 2016, 252 : E257 - E257
  • [6] Prognostic value of plasma adipokine chemerin in patients with coronary artery disease
    Wang, Bo
    Kou, Wenxin
    Ji, Shuya
    Shen, Rongrong
    Ji, Hongwei
    Zhuang, Jianhui
    Zhao, Yifan
    Li, Bo
    Peng, Wenhui
    Yu, Xuejing
    Li, Hailing
    Xu, Yawei
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Differential prognostic value of resistin for cardiovascular death in patients with stable coronary artery disease according to the presence of metabolic syndrome
    Kosmas, N.
    Katsimardos, A.
    Kountouri, A.
    Zolindaki, M.
    Rallidis, L.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1105 - 1105
  • [8] Associations between plasma ceramides and mortality in patients with coronary artery disease
    Li, Qing
    Wang, Xu
    Pang, Juan
    Zhang, Yuan
    Zhang, Hanyue
    Xu, Zhongliang
    Chen, Qian
    Ling, Wenhua
    [J]. ATHEROSCLEROSIS, 2020, 314 : 77 - 83
  • [9] Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease
    Bigalke, B.
    Stellos, L.
    Geisler, T.
    Seizer, P.
    May, A. E.
    Gawaz, M.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 444 - 444
  • [10] Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease
    Boris Bigalke
    Konstantinos Stellos
    Tobias Geisler
    Stephan Lindemann
    Andreas E. May
    Meinrad Gawaz
    [J]. Clinical Research in Cardiology, 2010, 99 : 227 - 233
12345